Phase 2 Study of ALLO-ASC-SHEET in Subjects With Diabetic Wagner Grade II Foot Ulcers
Diabetic Foot Ulcer
Enrolment: 64 · Results not recorded
Loading the evidence…
Biologic · Autologous/isogenic adipose tissue and adipose-derived stem cell preparations; no ChEMBL entity queried as no defined chemical entity exists. CLASS-LEVEL trial match only: recorded trials are human adipose-derived stem cell, stromal vascular fraction and fat-graft studies in diabetes, erectile dysfunction, lipofilling, alopecia and diabetic foot ulcer, none in trauma. NCT07394179 (zygomatic implant osteotomy) rejected as an unrelated surgical technique study. NCT02107118 is WITHDRAWN at 0 enrolment.
0 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.
Diabetic Foot Ulcer
Enrolment: 64 · Results not recorded
Type 1 Diabetes Mellitus
Enrolment: 30 · Results not recorded
Erectile Dysfunction · Cardiac Disease
Enrolment: 0 · Results not recorded
Skin Rejuvenation · Lipofilling
Enrolment: 15 · Results not recorded
Androgenetic Alopecia
Enrolment: 60 · Results not recorded
1 studies reported at therapy level; 1 evidence entries itemised.
Model: 30% total body surface area partial-thickness scald burn by exposure to 60 degrees Celsius water for 17 seconds
All treated groups showed decreased wound depth and area and reduced apoptotic activity compared with untreated burns. Groups containing adipose-derived stem cells showed a non-significant increase in vascularity at day 5 and no change in proliferation.
Extraction: extract · Subtype source: rule · Supplied extraction confidence: 0.9. Machine-extracted fields require source verification.